doxazosin

Generic: doxazosin mesylate

Labeler: upsher-smith laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin mesylate
Labeler upsher-smith laboratories, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 2 mg/1

Manufacturer
Upsher-Smith laboratories, LLC

Identifiers & Regulatory

Product NDC 0832-0357
Product ID 0832-0357_4367e154-1abf-01ad-e063-6394a90aca53
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209013
Marketing Start 2018-04-17
Marketing End 2027-08-31

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 08320357
Hyphenated Format 0832-0357

Supplemental Identifiers

RxCUI
197625 197626 197627 197628
UPC
0308321359112
UNII
86P6PQK0MU

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin mesylate (source: ndc)
Application Number ANDA209013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (0832-0357-11)
source: ndc

Packages (1)

0832-0357-11 100 TABLET in 1 BOTTLE (0832-0357-11)

Ingredients (1)

doxazosin mesylate (2 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4367e154-1abf-01ad-e063-6394a90aca53", "openfda": {"upc": ["0308321359112"], "unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["b5d1c604-ce3b-4973-845f-9db267a945cd"], "manufacturer_name": ["Upsher-Smith laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0832-0357-11)", "package_ndc": "0832-0357-11", "marketing_end_date": "20270831", "marketing_start_date": "20180417"}], "brand_name": "Doxazosin", "product_id": "0832-0357_4367e154-1abf-01ad-e063-6394a90aca53", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "0832-0357", "generic_name": "Doxazosin Mesylate", "labeler_name": "Upsher-Smith laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "2 mg/1"}], "application_number": "ANDA209013", "marketing_category": "ANDA", "marketing_end_date": "20270831", "marketing_start_date": "20180417"}